Variant report

Variant	nsv826222
Chromosome Location	chr12:7778855-7782399
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

Extended variants
information (count: 96 )
Associated
traits (count: 81 )

Variant overlapped rSNPs/rCNVs (count:96 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs186686962	chr12:7778868-7778869	Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
2	rs143366231	chr12:7778921-7778922	Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
3	rs191440036	chr12:7778951-7778952	Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
4	rs368626901	chr12:7778986-7778987	Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
5	rs115693443	chr12:7779016-7779017	Weak transcription Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs553507113	chr12:7779038-7779039	Weak transcription Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs372354040	chr12:7779060-7779061	Weak transcription Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs375794882	chr12:7779153-7779154	Weak transcription Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs12829339	chr12:7779227-7779228	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs11054921	chr12:7779240-7779241	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
11	rs7296689	chr12:7779241-7779242	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
12	rs6488529	chr12:7779288-7779289	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
13	rs538488769	chr12:7779349-7779350	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs79520392	chr12:7779617-7779618	Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
15	rs189163566	chr12:7779652-7779653	Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
16	rs112285086	chr12:7779743-7779744	Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
17	rs140122594	chr12:7779784-7779785	Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
18	rs577179634	chr12:7779832-7779833	Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
19	rs192874876	chr12:7779844-7779845	Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
20	rs367733452	chr12:7779929-7779930	Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
21	rs185351393	chr12:7779983-7779984	Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
22	rs372058392	chr12:7780093-7780094	Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
23	rs557133494	chr12:7780129-7780130	Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
24	rs189460962	chr12:7780146-7780147	Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
25	rs372007703	chr12:7780194-7780195	Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
26	rs529130322	chr12:7780287-7780288	Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
27	rs374982841	chr12:7780294-7780295	Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
28	rs534020944	chr12:7780327-7780328	Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
29	rs78223621	chr12:7780340-7780341	Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
30	rs74058954	chr12:7780388-7780389	Weak transcription Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
31	rs78411409	chr12:7780455-7780456	Weak transcription Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs542331058	chr12:7780546-7780547	Weak transcription Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs528319947	chr12:7780548-7780549	Weak transcription Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs75327664	chr12:7780553-7780554	Weak transcription Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs71038705	chr12:7780622-7780623	Weak transcription Enhancers Active TSS Bivalent/Poised TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
36	rs200566848	chr12:7780626-7780627	Weak transcription Enhancers Active TSS Bivalent/Poised TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
37	rs28605879	chr12:7780673-7780674	Weak transcription Enhancers Active TSS Bivalent/Poised TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
38	rs191793270	chr12:7780702-7780703	Weak transcription Enhancers Active TSS Bivalent/Poised TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
39	rs3040830	chr12:7780745-7780746	Weak transcription Enhancers Active TSS Bivalent/Poised TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
40	rs72384126	chr12:7780746-7780747	Weak transcription Enhancers Active TSS Bivalent/Poised TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
41	rs71038706	chr12:7780758-7780759	Weak transcription Enhancers Active TSS Bivalent/Poised TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
42	rs111255637	chr12:7780759-7780760	Weak transcription Enhancers Active TSS Bivalent/Poised TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
43	rs369654808	chr12:7780762-7780763	Weak transcription Enhancers Active TSS Bivalent/Poised TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
44	rs544558013	chr12:7780829-7780830	Active TSS Weak transcription Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs373074335	chr12:7780834-7780835	Active TSS Weak transcription Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs537407066	chr12:7780865-7780866	Active TSS Weak transcription Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs183651333	chr12:7780878-7780879	Active TSS Weak transcription Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs201557270	chr12:7780919-7780920	Active TSS Weak transcription Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs2004838	chr12:7780920-7780921	Active TSS Weak transcription Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
50	rs1860978	chr12:7780921-7780922	Active TSS Weak transcription Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:81)

Disease	PMID	Source
Acute lymphoblastic leukemia	22237106	CNVD
Breast cancer	17133270	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Medulloblastoma	16968546	CNVD
Ovine squamous-cell carcinoma	17599052	CNVD
Hepatocellular carcinoma	16750200	CNVD
T-cell acute lymphoblastic leukemia	20065082	CNVD
Breast cancer	22032731	CNVD
Cancer	21183584	CNVD
Myxofibrosarcoma	16751306	CNVD
Non-small cell lung cancer	21829676	CNVD
Ovarian neoplasms	16753589	CNVD
Prostate cancer	21965145	CNVD
Acute myeloid leukemia	16864856	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Disorders of sex development	21048976	CNVD
Glioblastoma multiforme	21080181	CNVD
Liposarcoma	21253554	CNVD
Prostate cancer	19156837	CNVD
Emphysema	19352772	CNVD
Medulloblastoma	21979893	CNVD
Basal cell lymphoma	17053054	CNVD
Malignant germ cell tumour	17285132	CNVD
Melanoma	18172304	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Wilms tumour	21544195	CNVD
Squamous cell cancer	21044232	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	19960244	CNVD
Endometrial cancer	22040021	CNVD
Colorectal cancer	20709793	CNVD
Breast cancer	21264507	CNVD
Cancer	16751803	CNVD
Testicular cancer	18059402	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Seminomas	18059402	CNVD
Esophageal cancer	21851588	CNVD
Lung cancer	20668451	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Testicular germ cell tumor	18059402	CNVD
Malaria	21533027	CNVD
Chronic lymphocytic leukemia	22228453	CNVD
Chronic lymphocytic leukemia	21670202	CNVD
Acute lymphoblastic leukemia	21248843	CNVD
Ewing''s sarcoma	17952124	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Breast cancer	21858162	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	21785460	CNVD
Myelodysplastic syndrome	21251322	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Autism	22495311	CNVD
Lung cancer	18438408	CNVD
small cell lung cancer	20016488	CNVD
Cancer	20164919	CNVD
Epilepsy	21858020	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Breast cancer	21364760	CNVD
Myelofibrosis	22110671	CNVD
Congenital diaphragmatic hernia	21085971	CNVD
craniofacial dysmorphism	21918468	CNVD
Malignant peripheral nerve sheath tumor	19844265	CNVD
Chronic lymphocytic leukemia	21049055	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Alzheimer''s disease	17160897	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Medullary thyroid carcinoma	18765511	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Non-syndromic sensorineural hearing loss	17289997	CNVD
Nasopharyngeal cancer	20548289	CNVD
head and neck squamous cell carcinoma	19451471	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:51 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr12:7775600-7791600	Weak transcription	Primary T helper memory cells from peripheral blood 1	blood
2	chr12:7777400-7780800	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
3	chr12:7777600-7781000	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
4	chr12:7778400-7779200	Active TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
5	chr12:7779000-7779200	Enhancers	HUES48 Cell Line	embryonic stem cell
6	chr12:7779200-7779400	Enhancers	HUES64 Cell Line	embryonic stem cell
7	chr12:7779200-7779600	Flanking Active TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
8	chr12:7779600-7782600	Active TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
9	chr12:7780400-7780600	Enhancers	Placenta	Placenta
10	chr12:7780400-7781600	Active TSS	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
11	chr12:7780600-7780800	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
12	chr12:7780600-7780800	Bivalent/Poised TSS	HUES64 Cell Line	embryonic stem cell
13	chr12:7780600-7780800	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
14	chr12:7780600-7781200	Flanking Active TSS	Placenta	Placenta
15	chr12:7780600-7781800	Active TSS	HUES6 Cell Line	embryonic stem cell
16	chr12:7780800-7781000	Bivalent Enhancer	H1 Derived Mesenchymal Stem Cells	ES cell derived
17	chr12:7780800-7781000	Flanking Bivalent TSS/Enh	HUES64 Cell Line	embryonic stem cell
18	chr12:7780800-7781000	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
19	chr12:7780800-7781200	Flanking Active TSS	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
20	chr12:7780800-7781200	Flanking Active TSS	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
21	chr12:7780800-7781200	Flanking Active TSS	ES-UCSF4 Cell Line	embryonic stem cell
22	chr12:7780800-7781200	Active TSS	Primary T cells from cord blood	blood
23	chr12:7780800-7781600	Active TSS	iPS DF 6.9 Cell Line	embryonic stem cell
24	chr12:7780800-7781800	Active TSS	ES-I3 Cell Line	embryonic stem cell
25	chr12:7780800-7781800	Active TSS	H1 Cell Line	embryonic stem cell
26	chr12:7780800-7781800	Active TSS	H9 Cell Line	embryonic stem cell
27	chr12:7780800-7781800	Active TSS	HUES48 Cell Line	embryonic stem cell
28	chr12:7781000-7781200	Flanking Bivalent TSS/Enh	H1 Derived Mesenchymal Stem Cells	ES cell derived
29	chr12:7781000-7781200	Flanking Bivalent TSS/Enh	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
30	chr12:7781000-7781200	Flanking Bivalent TSS/Enh	H9 Derived Neuron Cultured Cells	ES cell derived
31	chr12:7781000-7781200	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Female	--
32	chr12:7781000-7781200	Flanking Bivalent TSS/Enh	Fetal Muscle Trunk	muscle
33	chr12:7781000-7781200	Enhancers	Fetal Thymus	thymus
34	chr12:7781000-7781200	Enhancers	Gastric	stomach
35	chr12:7781000-7781200	Bivalent Enhancer	Right Ventricle	heart
36	chr12:7781000-7781600	Active TSS	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
37	chr12:7781000-7781600	Active TSS	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
38	chr12:7781000-7781800	Active TSS	HUES64 Cell Line	embryonic stem cell
39	chr12:7781200-7781400	Active TSS	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
40	chr12:7781200-7781400	Bivalent/Poised TSS	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
41	chr12:7781200-7781400	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
42	chr12:7781200-7781600	Active TSS	H1 Derived Mesenchymal Stem Cells	ES cell derived
43	chr12:7781200-7781600	Active TSS	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
44	chr12:7781200-7781600	Bivalent/Poised TSS	H9 Derived Neuron Cultured Cells	ES cell derived
45	chr12:7781200-7781600	Active TSS	Placenta	Placenta
46	chr12:7781200-7781800	Active TSS	ES-UCSF4 Cell Line	embryonic stem cell
47	chr12:7781400-7781600	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Female	--
48	chr12:7781600-7782200	Weak transcription	Placenta	Placenta
49	chr12:7781600-7782400	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
50	chr12:7781600-7782400	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links